Rob Waggener

Rob was most recently Chief Executive Officer at Foundations Recovery Network, LLC, before its sale to Universal Health Services, Inc. As CEO at FRN, Rob led the expansion and development of the company from startup to exit. Prior to FRN, he served as Chief Executive Officer of Lakeside Behavioral Health System.

Mark Richter

Dr. Mark Richter has more than 20 years of experience in the medical device startup environment.  He founded and served as president for MAX mobility, an assistive robotics company with multiple products including several kinds of robotic wheel chairs, among other assistive devices.  He led MAX mobility from startup to successful exit. He has served on Vanderbilt’s Mechanical Engineering External Advisory Board and holds the position of Adjunct Assistant Professor of Mechanical Engineering at Vanderbilt.

Thomas Kasser

Thomas R. Kasser previously held the role as Senior Vice President of Intrexon Corporation and built the foundation for taking the company public in 2013. He served on the executive team of Covance, Inc., with previous roles at Monsanto Company as General Manager and Senior Science Fellow. He retains a seat on the MFG Chemical Board of Directors after an 18-month tenure as CFO assisting Charles Gavin in the successful sale of the MFG Chemical business.

Charles Gavin

Charles founded and served as CEO of MFG Chemicals. He was the first to successfully develop acid-dyed filament carpet, now an industry standard. Charles was inducted into the Alabama Engineering Hall of Fame in 2016. He is a philanthropist, providing scholarship support to several universities, including a major gift to Auburn University to found the Gavin Engineering Research Building.

Michael Fabrizio


Michael D. Fabrizio, M.D., F.A.C.S., has been recognized by Castle and Connelly as a Top Urology Doctor in the United States and was involved in Computer Motion’s Zeus Robotic FDA trials. He has been involved in over 100 clinical trials for a range of applications and has a keen interest in minimally invasive surgery and advanced prostate cancer. He has been the President of the MidAtlantic Section of the American Urological Association and on the Board of the Large Urology Group Practice Association for 6 years. He most recently was CEO of Urology of Virginia from 2008 to 2019.

Brandon Ewing

Brandon Ewing was most recently CEO and President of Server Technology Inc., and he oversaw the growth of the company as it became a leading establishment in a lucrative marketplace. Brandon led the company in the expansion of manufacturing capabilities across the globe, including China, South Korea, Mexico and the U.S. He currently advises several companies on sales growth and product execution.

Martin Brown

Martin chairs a holding company with controlling interest in Brown-Forman Corporation, a NYSE-listed distiller of Jack Daniel’s and other fine whiskies. Martin served on the board of Brown-Forman for 10 years. He is an attorney with Adams and Reese and has served as board member or legal counsel for companies in various health care fields, including biotechnology, pharmaceuticals, wound care, and mental health services.

He is currently a director of the parent corporation of Aegis Sciences Corporation, a Nashville-based toxicology laboratory company.

Harry Jacobson

Dr. Jacobson is recently co-founder of TriStar Health Partners, where he acts as Managing Director, Partner and Principal. Formerly, he served as Vice Chancellor for Health Affairs at Vanderbilt University and CEO of Vanderbilt University Medical Center where he grew revenues from $750 million to $2.5 billion.

During the course of his career, Dr. Jacobson has been a successful investor and entrepreneur, having founded or co-founded 10 companies, such as Contact Software which was acquired by Symantec (SYMC:NASDAQ), and more recently Renal Care Group (RCG:NYSE) which was acquired by Fresenius Medical Care (FMS:NYSE) for approximately $4.0 billion.